NZ597818A - Probiotic derived non-viable material for allergy prevention and treatment - Google Patents
Probiotic derived non-viable material for allergy prevention and treatmentInfo
- Publication number
- NZ597818A NZ597818A NZ597818A NZ59781810A NZ597818A NZ 597818 A NZ597818 A NZ 597818A NZ 597818 A NZ597818 A NZ 597818A NZ 59781810 A NZ59781810 A NZ 59781810A NZ 597818 A NZ597818 A NZ 597818A
- Authority
- NZ
- New Zealand
- Prior art keywords
- treatment
- derived non
- allergy prevention
- viable material
- probiotic derived
- Prior art date
Links
- 208000026935 allergic disease Diseases 0.000 title abstract 2
- 230000002265 prevention Effects 0.000 title abstract 2
- 206010020751 Hypersensitivity Diseases 0.000 title 1
- 230000007815 allergy Effects 0.000 title 1
- 239000000463 material Substances 0.000 title 1
- 239000006041 probiotic Substances 0.000 title 1
- 230000000529 probiotic effect Effects 0.000 title 1
- 235000018291 probiotics Nutrition 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 3
- 241000917009 Lactobacillus rhamnosus GG Species 0.000 abstract 2
- 229940059406 lactobacillus rhamnosus gg Drugs 0.000 abstract 2
- 238000012365 batch cultivation Methods 0.000 abstract 1
- 239000012228 culture supernatant Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 235000016709 nutrition Nutrition 0.000 abstract 1
- 239000000047 product Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/065—Microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/38—Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factors; Stimulation of growth by removal of a chemical compound
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/304—Foods, ingredients or supplements having a functional effect on health having a modulation effect on allergy and risk of allergy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- General Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Pediatric Medicine (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09170124A EP2295535A1 (en) | 2009-09-11 | 2009-09-11 | Probiotic material |
| PCT/NL2010/050576 WO2011031149A1 (en) | 2009-09-11 | 2010-09-10 | Probiotic derived non-viable material for allergy prevention and treatment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ597818A true NZ597818A (en) | 2014-01-31 |
Family
ID=41561153
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ597818A NZ597818A (en) | 2009-09-11 | 2010-09-10 | Probiotic derived non-viable material for allergy prevention and treatment |
Country Status (20)
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20130095189A1 (en) * | 2011-10-14 | 2013-04-18 | Zeina Jouni | Composition and method of phytonutrients for metabolic programming effects |
| US20130251829A1 (en) * | 2012-03-23 | 2013-09-26 | Mead Johnson Nutrition Company | Probiotic derived non-viable material for infection prevention and treatment |
| US9138455B2 (en) | 2013-03-15 | 2015-09-22 | Mead Johnson Nutrition Company | Activating adiponectin by casein hydrolysate |
| US9345727B2 (en) * | 2013-03-15 | 2016-05-24 | Mead Johnson Nutrition Company | Nutritional compositions containing a peptide component and uses thereof |
| US9345741B2 (en) | 2013-03-15 | 2016-05-24 | Mead Johnson Nutrition Company | Nutritional composition containing a peptide component with adiponectin simulating properties and uses thereof |
| US8889633B2 (en) * | 2013-03-15 | 2014-11-18 | Mead Johnson Nutrition Company | Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof |
| US9289461B2 (en) | 2013-03-15 | 2016-03-22 | Mead Johnson Nutrition Company | Reducing the risk of autoimmune disease |
| US9352020B2 (en) | 2013-03-15 | 2016-05-31 | Mead Johnson Nutrition Company | Reducing proinflammatory response |
| US20150305384A1 (en) * | 2014-04-25 | 2015-10-29 | Mead Johnson Nutrition Company | Pediatric nutritional composition with human milk oligosaccahrides, prebiotics and probiotics |
| MX2016015153A (es) * | 2014-05-20 | 2017-03-07 | Biogaia Ab | Complementacion de microbioma neonatal. |
| US9730969B2 (en) | 2015-11-06 | 2017-08-15 | Mead Johnson Nutrition Company | Nutritional compositions for promoting gut barrier function and ameliorating visceral pain |
| US10034937B2 (en) | 2015-12-04 | 2018-07-31 | Mead Johnson Nutrition Company | Synergistic nutritional compositions and uses thereof |
| JP7057059B2 (ja) | 2016-08-22 | 2022-04-19 | 株式会社明治 | ラクトバチルス・プランタラムの培養物の製造方法 |
| US20180064739A1 (en) | 2016-09-06 | 2018-03-08 | Mead Johnson Nutrition Company | Nutritional composition with human milk oligosaccharides and uses thereof |
| US20180103675A1 (en) | 2016-10-14 | 2018-04-19 | Mead Johnson Nutrition Company | Personalized pediatric nutrition products comprising human milk oligosaccharides |
| US10980269B2 (en) | 2016-12-12 | 2021-04-20 | Mead Johnson Nutrition Company | Protein hydrolysates and methods of making same |
| US20180161292A1 (en) | 2016-12-12 | 2018-06-14 | Mead Johnson Nutrition Company | Nutritional compositions containing butyrate and uses thereof |
| US20180160714A1 (en) | 2016-12-12 | 2018-06-14 | Mead Johnson Nutrition Company | Nutritional compositions containing butyrate and uses thereof |
| US20180168215A1 (en) | 2016-12-21 | 2018-06-21 | Mead Johnson Nutrition Company | Nutritional compositions containing inositol and uses thereof |
| US20180332881A1 (en) | 2017-05-17 | 2018-11-22 | Mead Johnson Nutrition Company | Preterm infant formula containing butyrate and uses thereof |
| US20180333426A1 (en) | 2017-05-17 | 2018-11-22 | Mead Johnson Nutrition Company | Nutritional composition with human milk oligosaccharides and uses thereof |
| AU2018362747B2 (en) * | 2017-11-07 | 2025-08-14 | Hubit Genomix, Inc. | Method for primary prevention of allergic disorders during infancy through IgE-class-specific immunosuppression |
| US20190208807A1 (en) | 2018-01-05 | 2019-07-11 | Mead Johnson Nutrition Company | Nutritional compositions containing milk-derived peptides and uses thereof |
| EP3524051A1 (en) * | 2018-02-12 | 2019-08-14 | DuPont Nutrition Biosciences ApS | Matricial microencapsulation compositions |
| CN119040223B (zh) * | 2024-11-01 | 2025-02-28 | 微康益生菌(苏州)股份有限公司 | 一种具有抗炎抗敏功效的鼠李糖乳酪杆菌rh22及其应用 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4839281A (en) | 1985-04-17 | 1989-06-13 | New England Medical Center Hospitals, Inc. | Lactobacillus strains and methods of selection |
| US5407957A (en) | 1990-02-13 | 1995-04-18 | Martek Corporation | Production of docosahexaenoic acid by dinoflagellates |
| ZA92452B (en) | 1991-01-24 | 1992-10-28 | Martek Corp | Microbial oil mixtures and uses thereof |
| US5374567A (en) | 1993-05-20 | 1994-12-20 | The United States Of America As Represented By The Secretary Of The Navy | Operational amplifier using bipolar junction transistors in silicon-on-sapphire |
| FI104465B (fi) * | 1995-06-14 | 2000-02-15 | Valio Oy | Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö |
| US6506389B2 (en) | 1995-10-20 | 2003-01-14 | Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek (Tno) | Adherence factors of non pathogenic microorganisms and applications thereof for screening microorganisms for specific probiotic properties; novel pharmaceutical compositions and food additives comprising such microorganisms and adherence factors |
| CA2206674A1 (en) * | 1996-05-30 | 1997-11-30 | Gregor Reid | Lactobacillus therapies |
| EP0904784A1 (en) * | 1997-09-22 | 1999-03-31 | N.V. Nutricia | Probiotic nutritional preparation |
| WO2000071138A2 (en) * | 1999-05-25 | 2000-11-30 | Gregor Reid | Oral administration of lactobacillus for the maintenance of health in women |
| NZ536894A (en) | 2000-08-08 | 2006-04-28 | Vialactia Bioscience Nz Ltd | Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them |
| EP1458247B1 (en) * | 2001-12-20 | 2014-01-22 | Biolactis Inc. | Malleable protein matrix and uses thereof |
| EP1572145A1 (en) * | 2002-12-13 | 2005-09-14 | L'oreal | Use of an extract of decaffeinated coffee beans in the preparation of a composition intended to stimulate the sebaceous function of the skin by oral administration |
| US20040208863A1 (en) | 2003-01-30 | 2004-10-21 | James Versalovic | Anti-inflammatory activity from lactic acid bacteria |
| ATE433674T1 (de) * | 2003-06-23 | 2009-07-15 | Nestec Sa | Säuglingsnährpräparat oder folgemilch |
| JP2008501316A (ja) | 2004-04-20 | 2008-01-24 | ザ ユニヴァーシティー オヴ シカゴ | ラクトバシルスｇｇ由来プロバイオティック化合物及びそれらの使用 |
| US20100233312A9 (en) * | 2005-04-11 | 2010-09-16 | The Procter & Gamble Company | Compositions comprising probiotic and sweetener components |
| US20060233772A1 (en) * | 2005-04-15 | 2006-10-19 | Udo Herz | Method for preventing or treating the development of respiratory allergies |
| US7303745B2 (en) * | 2005-04-15 | 2007-12-04 | Bristol-Myers Squibb Company | Method for preventing or treating the development of respiratory allergies |
| US9133249B2 (en) * | 2006-10-24 | 2015-09-15 | Vanderbilt University | Compositions and methods for the treatment of disorders involving epithelial cell apoptosis |
| JP2010523695A (ja) * | 2007-04-11 | 2010-07-15 | アルコン リサーチ， リミテッド | アレルギー性鼻炎およびアレルギー性結膜炎を処置するためのＴＮＦαのインヒビターおよび抗ヒスタミン薬の使用 |
| WO2009137159A2 (en) * | 2008-04-17 | 2009-11-12 | Trustees Of Dartmouth College | Bioactive molecules produced by probiotic bacteria and methods for isolating and using the same |
-
2009
- 2009-09-11 EP EP09170124A patent/EP2295535A1/en not_active Ceased
-
2010
- 2010-09-10 MX MX2012002716A patent/MX345077B/es active IP Right Grant
- 2010-09-10 PL PL10757324T patent/PL2475764T3/pl unknown
- 2010-09-10 ES ES10757324.8T patent/ES2614929T3/es active Active
- 2010-09-10 JP JP2012528768A patent/JP2013504321A/ja active Pending
- 2010-09-10 WO PCT/NL2010/050576 patent/WO2011031149A1/en not_active Ceased
- 2010-09-10 BR BR112012005533A patent/BR112012005533A2/pt not_active Application Discontinuation
- 2010-09-10 KR KR1020127003851A patent/KR20120061836A/ko not_active Withdrawn
- 2010-09-10 MY MYPI2012000513A patent/MY160646A/en unknown
- 2010-09-10 US US12/879,136 patent/US20110217402A1/en not_active Abandoned
- 2010-09-10 AU AU2010293145A patent/AU2010293145B2/en not_active Ceased
- 2010-09-10 CN CN201080040659XA patent/CN102575224A/zh active Pending
- 2010-09-10 NZ NZ597818A patent/NZ597818A/en not_active IP Right Cessation
- 2010-09-10 PE PE2012000122A patent/PE20121557A1/es not_active Application Discontinuation
- 2010-09-10 EP EP10757324.8A patent/EP2475764B1/en not_active Not-in-force
- 2010-09-10 CA CA2772593A patent/CA2772593C/en not_active Expired - Fee Related
- 2010-09-10 IN IN951DEN2012 patent/IN2012DN00951A/en unknown
- 2010-09-10 RU RU2012114190/10A patent/RU2012114190A/ru not_active Application Discontinuation
- 2010-09-10 TW TW099130665A patent/TWI595090B/zh not_active IP Right Cessation
- 2010-09-10 SG SG2012007449A patent/SG178230A1/en unknown
-
2012
- 2012-04-05 EC ECSP12011786 patent/ECSP12011786A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SG178230A1 (en) | 2012-03-29 |
| EP2475764B1 (en) | 2016-12-14 |
| EP2475764A1 (en) | 2012-07-18 |
| ES2614929T3 (es) | 2017-06-02 |
| TWI595090B (zh) | 2017-08-11 |
| JP2013504321A (ja) | 2013-02-07 |
| IN2012DN00951A (cg-RX-API-DMAC7.html) | 2015-04-10 |
| US20110217402A1 (en) | 2011-09-08 |
| EP2295535A1 (en) | 2011-03-16 |
| TW201124529A (en) | 2011-07-16 |
| RU2012114190A (ru) | 2013-10-20 |
| KR20120061836A (ko) | 2012-06-13 |
| ECSP12011786A (es) | 2012-07-31 |
| PE20121557A1 (es) | 2012-11-21 |
| BR112012005533A2 (pt) | 2016-04-26 |
| CA2772593C (en) | 2018-11-27 |
| CA2772593A1 (en) | 2011-03-17 |
| MX2012002716A (es) | 2012-04-19 |
| MX345077B (es) | 2017-01-16 |
| PL2475764T3 (pl) | 2017-06-30 |
| AU2010293145A1 (en) | 2012-03-08 |
| AU2010293145B2 (en) | 2016-04-14 |
| MY160646A (en) | 2017-03-15 |
| CN102575224A (zh) | 2012-07-11 |
| WO2011031149A1 (en) | 2011-03-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ597818A (en) | Probiotic derived non-viable material for allergy prevention and treatment | |
| ATE421256T1 (de) | Probiotische zusammensetzung | |
| PH12018500566B1 (en) | Novel lactobacillus having various functions, and use thereof | |
| ATE285470T1 (de) | Lactobacillus helveticus, welches blutdrucksenkende di- und tripeptide herstellt | |
| WO2012149615A3 (en) | Polybacterial preparation with health benefits: antioxidant effect, reduction of cholesterol concentration, anti-inflammatory immunomodulating effect and release of bioactive peptides inhibiting angiotensin-converting enzyme | |
| UA111715C2 (uk) | Композиція, що містить пробіотичні бактерії для застосування у лікуванні імунних розладів | |
| AR042313A1 (es) | Composicion bacteriana y su uso para inmunomudulacion y prevencion de la enfermedad inflamatoria intestinal | |
| MX355955B (es) | Efecto antimicrobiano sinergico. | |
| WO2009138091A3 (en) | Isolated microorganism strain lactobacillus plantarum tensia dsm 21380 as antimicrobial and antihypertensive probiotic, food product and composition comprising said microorganism and use of said microorganism for preparation of antihypertensive medicine and method for suppressing pathogens and non-starter lactobacilli in food product | |
| NZ627915A (en) | Probiotic derived non-viable material for infection prevention and treatment | |
| WO2006065137A3 (en) | Novel efficient production process for capsular polysaccharides of pathogenic grampositive bacteria by heterologous expression and secretion of complex polysaccharides in non-pathogenic, non-invasive gram- positive bacteria | |
| BR112015019748A2 (pt) | Peptídeo tendo atividade inibitória da pl e/ou pla2, produto alimentício adequado para o tratamento da obesidade e/ou estresse oxidativo, e, uso de streptococcus thermophilus cncm i-2776 e/ou streptococcus thermophilus cncm i-1630 e/ou lactobacillus paracasei subsp paracasei cncm i-4270 | |
| FI20075539L (fi) | Maitohappobakteerit, joilla on proinflammatorisia ominaisuuksia | |
| NZ746671A (en) | Bifidobacteria for reducing food, energy and/or fat intake | |
| PH12023550118A1 (en) | Lactobacillus salivarus strain and its use in the prevention and treatment of urogenital tract dysbiosis | |
| WO2006119780A3 (en) | New antibiotic-sensitive lactic acid bacteria strains | |
| EA201692035A1 (ru) | Новый штамм lactobacillus casei, способный разрушать иммунотоксичный пептид глютена | |
| TW200730622A (en) | Microorganic culture having effect of skin inflammation inhibition and promotion of therapic effect of skin trauma and the product using the same | |
| WO2008002484A3 (en) | Novel lactobacillus bulgaricus strain and compositions | |
| MY140061A (en) | Improved method for the production of ramipril | |
| GR20110100600A (el) | Λειτουργικες επιτραπεζιες ελιες ζυμωμενες με γαλακτικα βακτηρια που διαθετουν προβιοτικες ιδιοτητες | |
| ATE536102T1 (de) | Probiotischer stamm von lactobacillus delbrueckii subsp bulgaricus | |
| WO2019145476A8 (en) | Composition comprising new lactobacillus salivarius strains and method for the prevention and treatment of otitis and upper respiratory infections | |
| RU2005125534A (ru) | Продукция витамина в12 в кисломолочных продуктах | |
| ATE423196T1 (de) | Antibiotikasensitive milchsäurebakterienstämme |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ASS | Change of ownership |
Owner name: MJN U.S. HOLDING, NZ Effective date: 20130808 |
|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 10 SEP 2017 BY CPA GLOBAL Effective date: 20140725 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 10 SEP 2018 BY CPA GLOBAL Effective date: 20170727 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 10 SEP 2019 BY CPA GLOBAL Effective date: 20180726 |
|
| LAPS | Patent lapsed |